Cargando…

Regional differences in health care of patients with inflammatory bowel disease in Germany

BACKGROUND: The regional availability of specialized physicians is an important aspect in healthcare of patients with IBD. The association between physician density and healthcare is not yet clear. Most studies did not consider district type, which reflects population density. Our research question...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lange, Ansgar, Prenzler, Anne, Bachmann, Oliver, Linder, Roland, Neubauer, Sarah, Zeidler, Jan, Manns, Michael P., von der Schulenburg, J.-Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608952/ https://www.ncbi.nlm.nih.gov/pubmed/26475276 http://dx.doi.org/10.1186/s13561-015-0067-1

Ejemplares similares

Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine
por: Prenzler, Anne, et al.
Publicado: (2011)

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
por: Lange, Ansgar, et al.
Publicado: (2014)

Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis -
por: Klora, Mike, et al.
Publicado: (2015)

Genome sequencing: a systematic review of health economic evidence
por: Frank, Martin, et al.
Publicado: (2013)

Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system
por: Kuhlmann, Alexander, et al.
Publicado: (2013)

Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016)

Note from the editor, January 2021
por: von der Schulenburg, J.-Matthias Graf, et al.
Publicado: (2021)

Nachhaltige Vergütung der B‑Zentren für Seltene Erkrankungen in Deutschland – Status quo und Lösungsansätze
por: Litzkendorf, Svenja, et al.
Publicado: (2022)

Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
por: Babac, Ana, et al.
Publicado: (2019)

Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany
por: Neubauer, Sarah, et al.
Publicado: (2014)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice
por: Babac, Ana, et al.
Publicado: (2019)

A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
por: Birkemeyer, Ralf, et al.
Publicado: (2020)

Rare Diseases on the Internet: An Assessment of the Quality of Online Information
por: Pauer, Frédéric, et al.
Publicado: (2017)

Quality of Life Is Associated With Wearable-Based Physical Activity in Patients With Inflammatory Bowel Disease: A Prospective, Observational Study
por: Wiestler, Miriam, et al.
Publicado: (2019)

Regional differences of outpatient physician supply as a theoretical economic and empirical generalized linear model
por: Scholz, Stefan, et al.
Publicado: (2015)

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines
por: Treskova, Marina, et al.
Publicado: (2016)

“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations
por: Staab, Thomas R., et al.
Publicado: (2018)

Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany
por: Wahler, S, et al.
Publicado: (2020)

Therapy preferences of patients with lung and colon cancer: a discrete choice experiment
por: Schmidt, Katharina, et al.
Publicado: (2017)

COVID-19: not the time for health economists? A plea for more proactive health economic involvement
por: Schulenburg, J.-Matthias Graf von der
Publicado: (2021)

Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study
por: Hafer, Anne, et al.
Publicado: (2007)

Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers
por: Hodek, Jan-Marc, et al.
Publicado: (2011)

Limitations to usual activities due to health problems in Germany
por: von der Lippe, Elena, et al.
Publicado: (2017)

Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease
por: Joos, Stefanie, et al.
Publicado: (2006)

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation
por: Ruof, Jörg, et al.
Publicado: (2013)

Healthcare service use in paediatric inflammatory bowel disease: a questionnaire on patient and parent care experiences in Germany
por: Boerkoel, Aletta, et al.
Publicado: (2023)

Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
por: Elias, Johannes, et al.
Publicado: (2010)

Occurrence and regional distribution of Aelurostrongylus abstrusus in cats in Germany
por: Barutzki, Dieter, et al.
Publicado: (2012)

Greetings from the Editors
por: Graf von der Schulenburg, J-Matthias, et al.
Publicado: (2011)

Evaluation of two family-based intervention programs for children affected by rare disease and their families – research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design
por: Boettcher, Johannes, et al.
Publicado: (2020)

Identification of Network Promoters in a Regional and Intersectoral Health Promotion Network: A Qualitative Social Network Analysis in Southern Germany
por: Fleuren, Tobias, et al.
Publicado: (2021)

Reduced Transferrin Levels in Active Inflammatory Bowel Disease
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

The impact of regional deprivation on stroke incidence, treatment, and mortality in Germany
por: Belau, Matthias Hans, et al.
Publicado: (2023)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse
por: Kuźnicki, Paweł, et al.
Publicado: (2021)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany
por: Haug, Ulrike, et al.
Publicado: (2014)

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany
por: Babac, Ana, et al.
Publicado: (2018)

Avoidance and Inhibition Do Not Predict Nonrespondent Bias Among Patients With Inflammatory Bowel Disease
por: Cámara, Rafael J. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ln82v628niv2hm61k45kbgg0c5